Contraception is more commonly known as fertility and birth control which are described as the methods to avoid pregnancy. These devices and drugs function by changing the mechanism of ovulation or by acting as a physical barrier between the sperm and ovum. Lack of contraception results in unwanted pregnancies and abortions which have an impact on healthcare costs. The provisions, planning and usage of contraceptives is known as family planning. The proper use of contraceptives such as female and male condoms also prevents the spread of sexually transmitted diseases. Family planning includes hormonal, barrier, sterilization and application of intra-uterine devices as methods for birth control. Apart from these there are also behavioral, dual protection and emergency controls available for prevention of pregnancy. The global market for contraceptives encompasses oral, vaginal, injectable contraceptive drugs and male/female contraceptive devices. These products are readily available at outlets ranging from pharmacies and chemists to reproductive health and fertility centers. All of the sexually active females within the childbearing age are at a risk of unwanted pregnancies due to unsafe sexual activity. The rapid rate of global population expansion poses a major cause for concern regarding birth control. This has resulted in an acute interest among the consumers to curb unplanned and unwanted pregnancies. Rising number of government initiatives directed towards curbing these unwanted abortion related expenses is the most significant driver of the global contraceptives market. Moreover, the presence of high contraception related needs of women (according to WHO the prevalence of women with unmet contraception needs was estimated at 200 million in 2011) and the rising global prevalence of sexually transmitted diseases also serves the market as a driver. The market for contraceptives is also influenced by political and social considerations. Owing to the transformations in regional demographics, cultural/sociological changes among nations and the constant rapid increase in the population world over combined with the global economic slowdown, the market for contraceptives is expected to witness a steady growth in demand throughout the forecast period.
Key product segments analyzed in this study include contraceptive drugs, male contraceptive devices and female contraceptive devices. The highest demand in the market is for contraceptives drugs. With the advancement in technology and development of new emergency oral contraceptive pills are seen as the easiest method of contraception. They act by prohibiting implantation within the uterus if taken within 2-3 days of having unsafe sexual contact. The simplicity of their usage makes them an ideal contraceptive in the market. The other forms of contraceptive drugs such as topical and injectable contraceptives also witness strong market demand. The future growth of the contraceptive drugs and devices market will be fuelled by the introduction of cheap contraceptives such as Sino-Implant (II) and the presence of an extensive contraceptives product pipeline (e.g. male contraceptive drugs, Pill-Plus and AG200-15 Contraceptive Patch).
North America, Europe, Asia Pacific and RoW are the major geographies analyzed in this study.
Europe and North America owing to the presence of sophisticated healthcare infrastructure, high adoption rate of contraceptive drugs and rising number of government initiatives pertaining to elevating user awareness levels dominated the overall market in 2013.However, the presence of high contraception related unmet medical needs coupled with rising user awareness levels and disposable incomes will help the Asia-Pacific contraceptive drugs and devices market to register the highest growth rate during the forecast period. The healthcare policies introduced in these countries aim at increasing the availability of contraceptive drugs and devices which would curb population increase.
Key players of this market include Bayer Healthcare AG, Merck & Co., Church & Dwight Co. Inc., Warmer Chilcott Company inc., Agile Therapeutics Inc., Pfizer Inc., BioSante Pharmaceuticals, Mayer Laboratories Inc., Pantarhei Bioscience B.V. and Teva Pharmaceutical Industries Ltd.
Avail customized purchase options to meet your research needs:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.